Pannekoek H, van Meijer M, Schleef R R, Loskutoff D J, Barbas C F
Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, Department of Molecular Biology, Amsterdam.
Gene. 1993 Jun 15;128(1):135-40. doi: 10.1016/0378-1119(93)90164-x.
The synthesis of the human plasminogen-activator inhibitor 1 (PAI-1) protein in the cytoplasm of transformed Escherichia coli cells results in inactive protein preparations that can be activated by denaturation and renaturation. We have used the phagemid pComb3, designed for combinatorial immunoglobulin repertoire cloning, for routing of PAI-1 to the periplasm and subsequent exposure on the surface of filamentous phages. Phage-displayed PAI-1 specifically binds to immobilized polyclonal and monoclonal anti-human PAI-1 antibodies. In addition, PAI-1 retains its capacity to form equimolar complexes with its target serine protease tissue-type plasminogen activator (t-PA), as well as its ability to inhibit t-PA activity. Finally, we have explored and manipulated the error-prone property of TaqI DNA polymerase during PCR amplification of the full-length PAI-1 cDNA to generate a large library of predominantly single, random PAI-1 mutants. In addition, a computer simulation program has been devised that converts the number of mutations per codogenic region (in this case PAI-1) into actual mutant proteins. The PAI-1-phage mutant library is composed of 46% single and 34% double mutants and 20% wild-type PAI-1 and can be employed to isolate mutants defective in interactions of PAI-1 with other components. The method described here is applicable to other studies on the structure-function analysis of eukaryotic proteins.
在转化的大肠杆菌细胞胞质中合成的人纤溶酶原激活物抑制剂1(PAI-1)蛋白会产生无活性的蛋白制剂,这些制剂可通过变性和复性来激活。我们使用了为组合免疫球蛋白库克隆设计的噬菌粒pComb3,将PAI-1转运到周质并随后展示在丝状噬菌体表面。噬菌体展示的PAI-1特异性结合固定化的多克隆和单克隆抗人PAI-1抗体。此外,PAI-1保留了与靶丝氨酸蛋白酶组织型纤溶酶原激活剂(t-PA)形成等摩尔复合物的能力,以及抑制t-PA活性的能力。最后,我们在全长PAI-1 cDNA的PCR扩增过程中探索并利用了TaqI DNA聚合酶的易错特性,以生成一个主要由单个随机PAI-1突变体组成的大型文库。此外,还设计了一个计算机模拟程序,可将每个编码区(在本例中为PAI-1)的突变数转化为实际的突变蛋白。PAI-1噬菌体突变体文库由46%的单突变体、34%的双突变体和20%的野生型PAI-1组成,可用于分离PAI-1与其他成分相互作用缺陷的突变体。本文所述方法适用于其他关于真核蛋白结构-功能分析的研究。